Home

Procter & Gamble Health Ltd EPS

Image

Procter & Gamble Health Ltd

NSE: PGHL

EPS

₹ 147.87

Last updated on: Apr 09, 2025

Key Highlights

  • The Earning per Share of Procter & Gamble Health Ltd is ₹ 147.87 as of 09 Apr 25 .
  • The earning per share of Procter & Gamble Health Ltd changed from ₹ 35.66 to ₹ 54.76 over 7 quarters. This represents a CAGR of 27.78% .

Historical Earning per Share of Procter & Gamble Health Ltd

No data available

* All values are in

Company Fundamentals for Procter & Gamble Health Ltd

Market Cap

8,659 Cr

EPS

147.9

P/E Ratio (TTM)

35.3

P/B Ratio (TTM)

14.2

Day’s High

5239.75

Day’s Low

5101.9

DTE

0.0

ROE

38.8

52 Week High

5835.95

52 Week Low

4640.3

ROCE

51.5

Market Price of Procter & Gamble Health Ltd

1M

1Y

3Y

5Y

Monitoring Procter & Gamble Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Apr 20255216.7
08 Apr 20255104.95
07 Apr 20255142
04 Apr 20255225.45
03 Apr 20255295.8
02 Apr 20255259.35
01 Apr 20255152.3
28 Mar 20255142.3
27 Mar 20254997.4
26 Mar 20255320.85

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Procter & Gamble Health Ltd

Asset Value vs Market Value of Procter & Gamble Health Ltd

Market Value

8,659

Asset Value

Value addition

14.5 X

558

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Procter & Gamble Health Ltd8659
Sun Pharmaceutical Industries Ltd396394
Divis Laboratories Ltd142920
Cipla Ltd114383
Torrent Pharmaceuticals Ltd105812
Mankind Pharma Ltd95481

Historical Market Cap of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Revenue of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical EBITDA of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Net Profit of Procter & Gamble Health Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Procter & Gamble Health Ltd News Hub

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, owing to c

Read more

22 Aug 24

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on

Read more

21 Aug 24

Procter & Gamble Health to pay final dividend

Procter & Gamble Health announced that final dividend of Rs 60 per share for FY 2024 will be paid by

Read more

21 Aug 24

Broader market outperforms; European mkt opens higher

The headline equity indices traded with decent gains in afternoon trade. The Nifty hovered above the

Read more

22 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Procter & Gamble Health Ltd

What is the EPS of Procter & Gamble Health Ltd stock?

The Earnings Per Share (EPS) of Procter & Gamble Health Ltd is 147.87. An EPS is the amount of net income attributed to each share of a common stock.

How is Procter & Gamble Health Ltd EPS calculated?

The EPS of Procter & Gamble Health Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Procter & Gamble Health Ltd report its EPS?

Procter & Gamble Health Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Procter & Gamble Health Ltd EPS?

Factors that influence the EPS of Procter & Gamble Health Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Procter & Gamble Health Ltd EPS growth indicate future performance?

Yes, consistent growth in Procter & Gamble Health Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions